CellSource Co (TSE:4880) Construction In Progress : 円0 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Construction In Progress?

CellSource Co's quarterly construction in progress increased from Jul. 2023 (円0 Mil) to Oct. 2023 (円414 Mil) but then declined from Oct. 2023 (円414 Mil) to Jan. 2024 (円0 Mil).

CellSource Co's annual construction in progress increased from Oct. 2021 (円76 Mil) to Oct. 2022 (円94 Mil) and increased from Oct. 2022 (円94 Mil) to Oct. 2023 (円414 Mil).

CellSource Co Construction In Progress Historical Data

The historical data trend for CellSource Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Construction In Progress Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Construction In Progress

Get a 7-Day Free Trial

62.56

59.01

76.36

94.26

414.22

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Construction In Progress	Get a 7-Day Free Trial															-	-	-	414.22	-

CellSource Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines